Who
Eric W. Roberts
Chief Business Officer
Company insider
Files Form 4 as: Chief Business Officer, CalciMedica; Director, Vivus; Director, Invuity; Other, Celator Pharmaceuticals.
In numbers
- Trades disclosed
- 238
- Buys
- 55
- Sells
- 9
- Bought
- $1.2M
- Sold
- $1.1M
- Companies
- 4
- Companies where not an officer
- 3
- First trade
- 6 Feb 2014
- Last trade
- 19 Aug 2026
- Last filed
- 21 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 Aug 2026filed 21 Aug 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —186,729 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —186,729 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —186,729 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —186,729 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | CALC CalciMedicaBiotechnology | SEC FORM 4 Code A | $150K186,729 at $0.8033 | filing |
| 25 Jun 2026filed 29 Jun 2026 | CALC CalciMedicaBiotechnology | SEC FORM 4 Code A | $149K186,729 at $0.80 | filing |
| 18 Sep 2025filed 22 Sep 2025 | CALC CalciMedicaBiotechnology | SEC FORM 4 Bought | $7,6752,500 at $3.07 | filing |
| 15 Sep 2025filed 17 Sep 2025 | CALC CalciMedicaBiotechnology | SEC FORM 4 Bought | $9,1123,400 at $2.68 | filing |
| 12 Sep 2025filed 15 Sep 2025 | CALC CalciMedicaBiotechnology | SEC FORM 4 Bought | $16K5,000 at $3.12 | filing |
| 9 Sep 2025filed 11 Sep 2025 | CALC CalciMedicaBiotechnology | SEC FORM 4 Bought | $7,3802,343 at $3.15 | filing |
| 29 Aug 2025filed 2 Sep 2025 | CALC CalciMedicaBiotechnology | SEC FORM 4 Bought | $2,192800 at $2.74 | filing |
| 28 Aug 2025filed 2 Sep 2025 | CALC CalciMedicaBiotechnology | SEC FORM 4 Bought | $26K9,200 at $2.86 | filing |
| 21 Aug 2025filed 25 Aug 2025 | CALC CalciMedicaBiotechnology | SEC FORM 4 Bought | $9,7873,508 at $2.79 | filing |
| 20 Aug 2025filed 21 Aug 2025 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code M | $23K15,000 at $1.53 | filing |
| 20 Aug 2025filed 21 Aug 2025 | CALC CalciMedicaBiotechnology | SEC FORM 4 Bought | $5,4402,000 at $2.72 | filing |
| 20 Aug 2025filed 21 Aug 2025 | CALC CalciMedicaBiotechnology | SEC FORM 4 Code M | $23K15,000 at $1.53 | filing |
| 19 Aug 2025filed 21 Aug 2025 | CALC CalciMedicaBiotechnology | SEC FORM 4 Bought | $2,7901,000 at $2.79 | filing |
| 15 Aug 2025filed 19 Aug 2025 | CALC CalciMedicaBiotechnology | SEC FORM 4 Bought | $15K5,076 at $2.90 | filing |
| 22 Jul 2025filed 23 Jul 2025 | CALC CalciMedicaBiotechnology | SEC FORM 4 Bought | $5,6701,500 at $3.78 | filing |
| 21 Jul 2025filed 22 Jul 2025 | CALC CalciMedicaBiotechnology | SEC FORM 4 Bought | $5,0551,500 at $3.37 | filing |
News
No headline names them, or the companies they trade most, lately.